کارخانجاتداروپخش
دارو | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 9,690 2.43
Close Price: 9,400
Financial Ratios
AGM
Interim
2026/06/17 Fiscal Year 2026/03/2012 Month | 2025/05/28 Fiscal Year 2025/03/2012 Month | 2024/06/02 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Net Profit to Sales | 31.07 | 14.59 | 8.98 | |
Gross Profit to Sales | 42.21 | 18.82 | 13.95 | |
Operating Margin | 48.68 | 30.34 | 26.27 | |
Gross Profit to Sales | 51.72 | 35.47 | 28.96 | |
Net Profit to Gross Profit | 60.08 | 41.13 | 30.99 | |
Return on Assets (ROA) | 19.82 | 5.64 | 7.13 | |
Return on Capital (%) | 51.81 | 208.69 | 124.53 | |
Return on Equity (ROE) | 32.87 | 9.42 | 46.22 | |
Working Capital Return | 78.29 | 60.18 | 66.8 | |
Fixed Asset Return | 52.26 | 10.57 | 87.1 | |
Loan Benefit Assessment | 1.66 | 1.67 | 6.48 | |
Current Ratio | 1.69 | 1.25 | 1.13 | |
Quick Ratio | 1.34 | 0.89 | 0.87 | |
Liquidity Ratio | 0.01 | 0.02 | 0.02 | |
Net Working Capital | 34,278,624 | 9,016,151 | 4,846,621 | |
Current Assets Ratio | 0.62 | 0.47 | 0.92 | |
Inventory Turnover | 133.46 | 170.56 | 136 | |
Receivables Collection Period | 253.94 | 282.21 | 311.04 | |
Inventory to Working Capital | 0.51 | 1.44 | 1.95 | |
Working Capital Turnover | 2.52 | 4.13 | 7.44 | |
Fixed Asset Turnover | 1.68 | 0.72 | 9.7 | |
Total Asset Turnover | 0.64 | 0.39 | 0.79 | |
Debt Ratio | 0.4 | 0.4 | 0.85 | |
Debt to Equity | 0.66 | 0.67 | 5.48 | |
Long-Term Debt to Equity | 0.05 | 0.05 | 0.23 | |
Current Debt to Equity | 0.61 | 0.62 | 5.25 | |
Equity Ratio | 60.28 | 59.92 | 15.43 | |
Debt Coverage Ratio | 12.69 | 18.58 | 2.32 |
